אזטרול 10 מ"ג טבליות

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

EZETIMIBE 10 MG

Commercializzato da:

MERCK SHARP & DOHME ISRAEL LTD

Codice ATC:

C10AX09

Forma farmaceutica:

TABLETS

Via di somministrazione:

PER OS

Prodotto da:

MERCK SHARP & DOHME CORP., USA

Gruppo terapeutico:

EZETIMIBE

Indicazioni terapeutiche:

Primary hypercholesterolemia: Ezetrol administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezetrol administered with a statin are indicated for use in patients with HoFH.Patients may also receive adjunctive treatments (e.g. LDL apheresis).Homozygous sitosterolemia (Phytosterolemia): Ezetrol are indicated for use in patients with homozygous familial sitosterolemia.

Data dell'autorizzazione:

2013-05-01